Discovery of adamantane-type polycyclic polyprenylated acylphloroglucinols that can prevent concanavalin A-induced autoimmune hepatitis in mice

Bioorg Chem. 2024 Mar:144:107145. doi: 10.1016/j.bioorg.2024.107145. Epub 2024 Jan 23.

Abstract

Hyperadamans A-G (1-7), seven new adamantane type polycyclic polyprenylated acylphloroglucinols (PPAPs), were isolated from Hypericum wilsonii N. Robson. Structurally, 1-4 were the first adamantanes bearing an unusual 2,7-dioxabicyclo-[2.2.1]-heptane fragment, and compound 5 was the first adamantane with a rare 1,6-dioxaspiro[4.4]nonane section. Importantly, 1-7 exhibited significant immunosuppressive activity on Con A-induced T-lymphocyte proliferation in vitro, with IC50 values ranging from 3.97 ± 0.10 to 18.12 ± 1.07 μM. Pretreatment with 1 in Con A-challenged autoimmune hepatitis mice could dramatically ameliorate the levels of hepatic injury indexes (ALT and AST) and reduce the product of proinflammatory cytokines (COX-2, IL-6, IL-1β, IL-18, IL-23A and TNF-α). Furthermore, the protective effect of 1 on the Con A-induced liver injury was corroborated by the histological analysis and the immunohistochemistry.

Keywords: Adamantane; Autoimmune hepatitis; Hypericum wilsonii N. Robson; Polycyclic polyprenylated acylphloroglucinols.

MeSH terms

  • Adamantane* / chemistry
  • Adamantane* / pharmacology
  • Animals
  • Concanavalin A
  • Cytokines
  • Hepatitis, Autoimmune* / drug therapy
  • Hepatitis, Autoimmune* / prevention & control
  • Mice
  • Molecular Structure
  • Tumor Necrosis Factor-alpha

Substances

  • Concanavalin A
  • Adamantane
  • Cytokines
  • Tumor Necrosis Factor-alpha